The SYNTAX Score and SYNTAX-Based Clinical Risk Scores

Seminars in Thoracic and Cardiovascular Surgery

Volumn 23, Issue 2, 2011, Pages 99-105

  Farooq, Vasim ^a   Brugaletta, Salvatore ^a   Serruys, Patrick W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

ACEF; Clinical syntax score; Global Risk; Modified ACEF; SYNTAX score

Indexed keywords

ANGIOCARDIOGRAPHY; ARTICLE; CEREBROVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DECISION MAKING; EUROSCORE; FRACTIONAL FLOW RESERVE; FRAMINGHAM RISK SCORE; HEART DISEASE; HEART MUSCLE REVASCULARIZATION; HUMAN; MORBIDITY; NON INVASIVE PROCEDURE; OUTCOME ASSESSMENT; PARSONNET SCORE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROGNOSIS; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SCORING SYSTEM; SYNTAX SCORE; THORAX SURGERY;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; DECISION SUPPORT SYSTEMS, CLINICAL; HUMANS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 82755187581     PISSN: 10430679     EISSN: 15329488     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2011.08.001     Document Type: Article

References (37)

1. Wijns W., Kolh P., Danchin N., et al. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010, 31:2501-2555.
2. Serruys P.W., Morice M.C., Kappetein A.P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 2009, 360:961-972.
3. Kappetein A.P., Feldman T.E., Mack M.J., et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial. Eur Heart J 2011, 32:2125-2134.
4. Nashef S.A., Roques F., Michel P., et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg 1999, 16:9-13.
5. Roques F., Michel P., Goldstone A.R., et al. The logistic EuroSCORE. Eur Heart J 2003, 24:881-882.
6. Shahian D.M., O'Brien S.M., Filardo G., et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 1-Coronary artery bypass grafting surgery. Ann Thorac Surg 2009, 88(suppl):S2-S22.
7. Serruys P.W., Onuma Y., Garg S., et al. Assessment of the SYNTAX score in the Syntax study. EuroIntervention 2009, 5:50-56.
8. Mohr F.W., Rastan A.J., Serruys P.W., et al. Complex coronary anatomy in coronary artery bypass graft surgery: Impact of complex coronary anatomy in modern bypass surgery?. Lessons learned from the SYNTAX trial after two years. J Thorac Cardiovasc Surg 2011, 141:130-140.
9. Sianos G., Morel M.A., Kappetein A.P., et al. The SYNTAX Score: An angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005, 1:219-227.
10. Romagnoli E., Burzotta F., Trani C., et al. EuroSCORE as predictor of in-hospital mortality after percutaneous coronary intervention. Heart 2009, 95:43-48.
11. Kim Y.H., Ahn J.M., Park D.W., et al. EuroSCORE as a predictor of death and myocardial infarction after unprotected left main coronary stenting. Am J Cardiol 2006, 98:1567-1570.
12. Kim Y.-H., Park D.-W., Kim W.-J., et al. Validation of SYNTAX (Synergy between PCI with Taxus and Cardiac Surgery) score for prediction of outcomes after unprotected left main coronary revascularization. J Am Coll Cardiol Interv 2010, 3:612-623.
13. Leaman D.M., Brower R.W., Meester G.T., et al. Coronary artery atherosclerosis: Severity of the disease, severity of angina pectoris and compromised left ventricular function. Circulation 1981, 63:285-299.
14. SYNTAX working-group: SYNTAX score calculator Launched May 19, 2009. http://www.syntaxscore.com.
15. Serruys P.W., Onuma Y., Garg S., et al. 5-Year clinical outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the sirolimus-eluting stent in the treatment of patients with multivessel de novo coronary artery lesions. J Am Coll Cardiol 2010, 55:1093-1101.
16. Okwuosa T.M., Greenland P., Ning H., et al. Distribution of coronary artery calcium scores by Framingham 10-year risk strata in the MESA (Multi-Ethnic Study of Atherosclerosis) potential implications for coronary risk assessment. J Am Coll Cardiol 2011, 57:1838-1845.
17. Tonino P.A., Fearon W.F., De Bruyne B., et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010, 55:2816-2821.
18. Pijls N.H., Fearon W.F., Tonino P.A., et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-Year follow-up of the FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010, 56:177-184.
19. Fearon WF: Functional Syntax score. Presented at Left Main Coronary Interventions Course, February 14, 2011, New York, NY.
20. Cutlip D.E., Mehran R., Vranckx P. FAME and coronary stent investigations: Is there a kink in the wire?. J Am Coll Cardiol 2011, 57:115-116. author reply 116.
21. Yong A.S., Ng A.C., Brieger D., et al. Three-dimensional and two-dimensional quantitative coronary angiography, and their prediction of reduced fractional flow reserve. Eur Heart J 2011, 32:345-353.
22. Parsonnet V., Dean D., Bernstein A.D. A method of uniform stratification of risk for evaluating the results of surgery in acquired adult heart disease. Circulation 1989, 79:I3-I12.
23. Valgimigli M., van Mieghem C.A.G., Ong A.T.L., et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: Insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital Registries (RESEARCH and T-SEARCH). Circulation 2005, 111:1383-1389.
24. Chakravarty T., Buch M.H., Naik H., et al. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization. Am J Cardiol 2011, 107:360-366.
25. Wykrzykowska J.J., Garg S., Onuma Y., et al. Value of age, creatinine, and ejection fraction (ACEF score) in assessing risk in patients undergoing percutaneous coronary interventions in the "All-Comers" LEADERS trial. Circ Cardiovasc Interventions 2011, 4:47-56.
26. Ranucci M., Castelvecchio S., Menicanti L., et al. Risk of assessing mortality risk in elective cardiac operations: Age, creatinine, ejection fraction, and the law of parsimony. Circulation 2009, 119:3053-3061.
27. Ranucci M., Castelvecchio S. The ACEF score one year after: A skeleton waiting for muscles, skin, and internal organs. EuroIntervention 2010, 6:549-553.
28. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:31-41.
29. Garg S., Sarno G., Garcia-Garcia H.M., et al. A new tool for the risk stratification of patients with complex coronary artery disease: The Clinical SYNTAX Score. Circ Cardiovasc Interventions 2010, 3:317-326.
30. Capodanno D., Caggegi A., Miano M., et al. Global Risk classification and Clinical SYNTAX (Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery) score in patients undergoing percutaneous or surgical left main revascularization. J Am Coll Cardiol Interv 2011, 4:287-297.
31. Serruys PW: Integrating lessons from recent clinical trials into practice: Beyond the SYNTAX score. Presented at Transcatheter Therapeutics Asia Pacific, April 29, 2010, Seoul, South Korea.
32. Rodés-Cabau J., Deblois J., Bertrand O.F., et al. Nonrandomized comparison of coronary artery bypass surgery and percutaneous coronary intervention for the treatment of unprotected left main coronary artery disease in octogenarians. Circulation 2008, 118:2374-2381.
33. Min S.Y., Park D.W., Yun S.C., et al. Major predictors of long-term clinical outcomes after coronary revascularization in patients with unprotected left main coronary disease: Analysis from the MAIN-COMPARE study. Circ Cardiovasc Interventions 2010, 3:127-133.
34. Capodanno D., Miano M., Cincotta G., et al. EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention. Am Heart J 2010, 159:103-109.
35. Federspiel J., Stearns S.C., van Domburg R., et al. Risk-benefit trade-offs in revascularisation choices. EuroIntervention 2011.
36. Ong A.T., Serruys P.W., Mohr F.W., et al. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phase. Am Heart J 2006, 151:1194-1204.
37. Gogbashian A., Sedrakyan A., Treasure T. EuroScore: A systematic review of international performance. Eur J Cardiothorac Surg 2004, 25:695-700.